Hyperpolarized Carbon-13 MRI in Breast Cancer
R Woitek, KM Brindle - Diagnostics, 2023 - mdpi.com
One of the hallmarks of cancer is metabolic reprogramming, including high levels of aerobic
glycolysis (the Warburg effect). Pyruvate is a product of glucose metabolism, and 13C-MR …
glycolysis (the Warburg effect). Pyruvate is a product of glucose metabolism, and 13C-MR …
PROMRIINE (PRe-operatory magnetic resonance imaging is INEffective) Study: a systematic review and meta-analysis of the impact of magnetic resonance imaging …
A Mattar, M Antonini, A Amorim, EF Mateus… - Annals of Surgical …, 2024 - Springer
Background The purpose of this study was to review and summarize the association
between preoperative magnetic resonance imaging (MRI) and surgical outcomes in women …
between preoperative magnetic resonance imaging (MRI) and surgical outcomes in women …
Deep Learning‐Based Segmentation of Locally Advanced Breast Cancer on MRI in Relation to Residual Cancer Burden: A Multi‐Institutional Cohort Study
MHA Janse, LM Janssen… - Journal of Magnetic …, 2023 - Wiley Online Library
Background While several methods have been proposed for automated assessment of
breast‐cancer response to neoadjuvant chemotherapy on breast MRI, limited information is …
breast‐cancer response to neoadjuvant chemotherapy on breast MRI, limited information is …
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
LM Janssen, MHA Janse, BBL Penning de Vries… - NPJ Breast …, 2024 - nature.com
Accurate prediction of response to neoadjuvant chemotherapy (NAC) can help tailor
treatment to individual patients' needs. Little is known about the combination of liquid …
treatment to individual patients' needs. Little is known about the combination of liquid …
Soluble NKG2DLs are elevated in breast cancer patients and associate with disease outcome
A Seller, CM Tegeler, J Mauermann… - International journal of …, 2024 - mdpi.com
Ligands of the natural killer group 2D (NKG2DL) family are expressed on malignant cells
and are usually absent from healthy tissues. Recognition of NKG2DLs such as MICA/B and …
and are usually absent from healthy tissues. Recognition of NKG2DLs such as MICA/B and …
Prediction of primary tumour and axillary lymph node response to neoadjuvant chemo (targeted) therapy with dedicated breast [18F] FDG PET/MRI in breast cancer
CM de Mooij, TJA van Nijnatten, B Goorts… - Cancers, 2023 - mdpi.com
Simple Summary Neoadjuvant chemo (targeted) therapy (NCT) can downstage disease
burden in breast cancer, allowing less invasive surgery. The ability of sequential hybrid [18F] …
burden in breast cancer, allowing less invasive surgery. The ability of sequential hybrid [18F] …
Diffusion-weighted imaging in addition to contrast-enhanced MRI in identifying complete response in HER2-positive breast cancer
A van der Voort, KJJ van der Hoogt, R Wessels… - European …, 2024 - Springer
Objectives The aim of this study is to investigate the added value of diffusion-weighted
imaging (DWI) to dynamic-contrast enhanced (DCE)-MRI to identify a pathological complete …
imaging (DWI) to dynamic-contrast enhanced (DCE)-MRI to identify a pathological complete …
89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A …
DGJ Linders, MM Deken, MA van Dam, M Wasser… - Cancers, 2023 - mdpi.com
Simple Summary In breast cancer patients in whom tumor cells overexpress the protein
human epidermal growth factor receptor 2 (HER2), HER2-targeted therapy is the mainstay of …
human epidermal growth factor receptor 2 (HER2), HER2-targeted therapy is the mainstay of …
Neoadjuvant pegylated liposomal doxorubicin-and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control …
JH Tsai, CL Li, DC Yeh, CS Hung, CC Hung… - Breast Cancer Research …, 2023 - Springer
Purpose This study aimed to compare the effectiveness and safety of pegylated liposomal
doxorubicin (PLD)-based and epirubicin-based combination therapy regimen as …
doxorubicin (PLD)-based and epirubicin-based combination therapy regimen as …
[HTML][HTML] Performance of Contrast-Enhanced Mammography (CEM) for Monitoring Neoadjuvant Chemotherapy Response among Different Breast Cancer Subtypes
S Vidali, G Irmici, C Depretto, C Bellini, F Pugliese… - Cancers, 2024 - mdpi.com
Simple Summary The indications for neoadjuvant chemotherapy (NAT) have expanded in
recent years both for locally advanced and early-stage breast cancer, with different …
recent years both for locally advanced and early-stage breast cancer, with different …